BRIEF-Essa Pharma Reports Qtrly Loss Per Share Of $0.07
Dec 11 (Reuters) - ESSA Pharma Inc:
* ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017
* QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.07‍​
* ‍CASH ON HAND AS AT SEPTEMBER 30, 2017 WAS $3.98 MILLION, WITH WORKING CAPITAL OF $1.28 MILLION​ Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )